PRM-151-202:  A Phase 2 Trial to Evaluate the Efficacy of PRM-151 in Subjects with Idiopathic Pulmonary Fibrosis (IPF)

Recruitment has ended and screening has closed for our PRM-151-202 Study. Please view our company website at for future updates on PRM-151. Thank you,

The PROMOTE Clinical Operations Team

‚ÄčLocations of Active Clinical Research Sites:

United States, California

Facility:  UCSF Interstitial Lung Disease Program

 San Francisco, California

 Principal Investigator:  Jeffrey Golden, MD

 Contact:  Fizaa Ahmed  415-502-1958



United States, Colorado

Facility:  National Jewish Medical and Research Center

 Denver, Colorado

 Principal Investigator:  Tristan Huie, MD

 Contacts:  Cori Fratelli  303-270-2566


                    Jami Henriksen


United States, Connecticut

Facility:  Yale University School of Medicine
 New Haven, Connecticut
 Principal Investigator:  Danielle Antin-Ozerkis, MD
 Contact:   Christina Lakomski, RN  203-785-4163

United States, Kansas

Facility:  University of Kansas Medical Center
 Kansas City, Kansas
 Principal Investigator:  Mark Hamblin, MD
 Contact:  Kimberly Lovell  913-588-6067

United States, Kentucky

Facility:  University of Louisville School of Medicine

 Louisville, Kentucky

 Principal Investigator:  Rafael Perez, MD

 Contact:  Tamra Perez, RN  502-852-1358


United States, Massachusetts

Facility:  Massachusetts General Hospital

 Boston, Massachusetts

 Principal Investigator:  Leo C. Ginns, MD

 Contact:  Rohan Rao  617-724-2604


United States, Texas

Facility:  UT - Southwestern Medical School

 Dallas, Texas

 Principal Investigator:  Corey Dean Kershaw, MD

 Contact:  Rhoda Annoh Gordon  214-645-7108


‚ÄčUnited States, Virginia

Facility:  Inova Fairfax Hospital
 Falls Church, Virginia
 Principal Investigator:  Anne Brown, MD
 Contact:  Stephanie Garofalo  703-776-2018

United States, Washington

Facility:  University of Washington Medical Center
 Seattle, Washington
 Principal Investigator:  Lawrence Ho, MD
 Contact:  Genecelle Delossantos  206-779-9496

United States, Wisconsin

Facility:  University of Wisconsin-Madison

 Madison, Wisconsin

 Principal Investigator:  Keith Meyer, MD

 Contact:  Larry Westby  608-262-0927


Czech Republic

Facility:  Thomayer Hospital

 Prague, Czech Republic

 Principal Investigator: Martina Vasakova, MD

 Contact:  Martina Sterclova  420 261082372



Facility:  Justus-Liebig University Giessen

 Giessen, Germany

 Principal Investigator:  Andreas Gunther, MD

 Contact:  Sabine Heinemann  0049  64198542558



Facility:  Thoraxklinik University of Heidelberg

 Heidelberg, Germany

 Principal Investigator:  Michael Kreuter, MD  

 Contact:  Beate Schaufler  004962213960



Facility:  Az. Ospedaliera Universitaria-Policlinico V. Emanuele di Catania

 Catania, Italy

 Principal Investigator:  Carlo Vancheri, MD

 Contact:  Elisa Gili  0039 095 3781253



Facility: Azienda Ospedaliera San Gerardo

 Monza, Italy

 Principal Investigator:  Alberto Pesci, MD

 Contact:  Giulia Bonaiti, MD  0039 039 2333379



Facility:  Erasmus Medical Center
 Rotterdam, Zuid Holland
 Principal Investigator:  Marlies Wijsenbeek, MD
 Contact:  Annemarie Geel  +31 010 703 56


Facility:  Hospital University de Bellvitge

 Barcelona, Spain

 Principal Investigator:  Maria Molina, MD

 Contact:  Pilar Rivera Ortega  +0034 671670301



Facility:  CHUV Centre Hospitalier Universitaire Vaudois

 Lausanne, Switzerland

 Principal Investigator:  Romain Lazor, MD

 Contacts:  Selma Ahmetovic  +41 79 556 34 12


                    Mary-Line Wiasemsky  +41 79 556 46 62